Sandra Aung, PhD, has been named the executive vice president and head of clinical development of Ambrx Biopharma, a pharmaceutical engineering company.
Dr. Aung has 20 years of experience in the biotechnology and pharmaceutical industry and has led oncology-focused clinical development teams and projects, according to a Feb. 3 news release from the company.
In her new role, Dr. Aung will lead the development of several Ambrx product candidates.